Your Followed Topics

Top 264 health News Today

#1
Findings on healthy life expectancy in UK shed light on its deteriorating health
#1 out of 26414.96%
health6h ago

Findings on healthy life expectancy in UK shed light on its deteriorating health

https://www.theguardian.com/uk-news/2026/apr/27/findings-healthy-life-expectancy-uk-shed-light-deteriorating-healthhttps://www.bbc.com/news/articles/c20q07w3gl9ohttps://streamlinefeed.co.ke/news/britain-s-health-crisis-new-data-reveals-sharp-decline-in-healthy-life-expectancy
Theguardian.com and 2 more
  • UK healthy life expectancy fell by two years across the population from 2012-14 to 2022-24, signaling a broad national health challenge.
  • In 2022-24, healthier life expectancy varies sharply by deprivation, with about 69 years for the least deprived men and around 50 for the most deprived men.
  • Public health experts call for a watershed moment, shifting focus from treatment to prevention through housing and nutrition investments and social care reform.
Vote 5
0
#2
Stress during pregnancy? Early skills may help children cope
#2 out of 2643.53%
health6h ago

Stress during pregnancy? Early skills may help children cope

https://www.euronews.com/health/2026/04/27/as-climate-disasters-grow-early-skills-may-help-childrens-brains-before-they-are-born-studhttps://sg.news.yahoo.com/climate-disasters-grow-early-skills-050304344.htmlhttps://ca.news.yahoo.com/climate-disasters-grow-early-skills-050304893.html
Euronews.com and 2 more
  • A small CUNY-Queens College study used prenatal exposure to Superstorm Sandy as a model to examine how early-life stress may shape brain development before birth.
  • Between ages 2 and 6, researchers tracked everyday skills such as communication, self-care, and social behavior to gauge developmental impact.
  • At age 8, brain imaging revealed that stressed-exposed children with higher adaptive skills showed brain activity resembling that of non-exposed peers in emotion-processing tasks.
  • Resilience appeared linked more to adaptive skills than prenatal stress alone, suggesting skills development supports brain resilience.
  • Children with lower adaptive skills showed reduced activity in key emotion-related brain regions, including the limbic system.
  • The authors propose early interventions focused on everyday skills to bolster brain resilience in children exposed to prenatal stress.
  • Findings are preliminary due to a small sample, underscoring the need for larger, more definitive studies.
  • Lead researcher Yoko Nomura cautions that rising disaster frequency may increase stress for pregnant women, influencing outcomes.
  • The study emphasizes building adaptive skills not only for behavior but also as a potential way to protect brain health.
  • The study uses prenatal exposure to a natural disaster as a model to explore potential long-term brain effects of early stress.
  • The research focused on emotion-related brain activity to assess resilience and how early adaptive skills may shape later outcomes.
Vote 2
0
#3
Kai Trump reveals medical 'scare' during her trip to The Masters
#3 out of 26410.01%
health18h ago

Kai Trump reveals medical 'scare' during her trip to The Masters

https://www.dailymail.com/sport/golf/article-15766647/kai-trump-medical-emergency-augusta-masters.htmlhttps://nypost.com/2026/04/26/sports/kai-trump-opens-up-on-scary-medical-ordeal-during-masters/https://www.foxnews.com/sports/kai-trump-reveals-scary-medical-moment-trip-masters-tournament-augusta-national
Dailymail.com and 2 more
  • Kai Trump describes a scary allergic reaction at the Masters that required medical attention, signaling a standout moment amid Augusta National's proceedings.
  • The incident involved Kai Trump using hand soap on her face at Augusta, which led to facial bumps and concern during the event.
  • The reaction was resolved after a steroid shot, and Kai Trump states she recovered from the scare.
  • Despite the scare, Kai Trump continued to enjoy weekend action at Augusta National and kept plans to watch the tournament.
  • Kai Trump is set to join the University of Miami golf program, signaling a transition to collegiate competition.
  • Her social media presence is substantial, with nearly 1.5 million YouTube subscribers documenting her life on and off the course.
  • The original report of the incident credited the Daily Mail for first revealing Kai Trump’s Masters visit and medical moment.
  • Kai Trump attended Augusta alongside notable figures including Bryson DeChambeau, highlighting her connection to top golf circles.
  • The Masters winner for that year was Rory McIlroy, who secured a second consecutive green jacket as Kai Trump’s weekend progressed.
Vote 2
0
#4
Streaming is the 'sensual' act adored by 20 million women
#4 out of 264
health1m ago

Streaming is the 'sensual' act adored by 20 million women

  • Metro reports that 62% of women have practiced streaming, a water-based masturbation method described as using shower pressure on the vulva.
  • Experts say streaming involves targeted water pressure on the clitoris or vulva, with variations like rainforest or straight streams.
  • The guidance warns against inserting water inside the vagina and stresses external clitoral stimulation is safer.
  • The article cites OMGYES as the source naming streaming and describes how showers can be a private space for self-pleasure.
  • Experts advise warming up the body before focusing on the vulva and experimenting with water temperature.
  • The piece notes privacy concerns, suggesting showers are private in homes but not in shared spaces like pools or hot tubs.
  • The article frames streaming as a private, customizable experience with different water pressures and flow patterns.
  • Gigi Engle, a sex expert, describes streaming as a discreet way to self-pleasure in private settings.
  • The piece notes that streaming can involve aiming water at different areas, including the clitoral hood and vulva, with varying sensations.
  • The Metro article links streaming to broader sexual education resources and female empowerment in private spaces.
Vote 0
0
#5
Grace updates corporate presentation detailing FDA CRL for GTx-104 and Phase 3 trial data
#5 out of 264
business5m ago

Grace updates corporate presentation detailing FDA CRL for GTx-104 and Phase 3 trial data

  • Grace reports an FDA Complete Response Letter for GTx-104 due to CMC and manufacturing readiness issues.
  • Grace plans a Type A meeting with the FDA and aims to resubmit after fixing CMC and leachable issues.
  • Phase 3 STRIVE-ON safety results show fewer hypotension events with GTx-104 versus oral nimodipine.
  • STRIVE-ON topline indicates a roughly 29% rise in 90-day recoveries with higher dose intensity.
  • Grace notes reduced ICU/ventilator days and fewer readmissions in STRIVE-ON topline data.
  • The updated exhibit 99.1 was incorporated into Grace's Form 8-K on April 27, 2026.
  • Grace positions a strategic path to NDA resubmission pending regulatory clearance.
  • Grace emphasizes the Phase 3 STRIVE-ON data for clinical and pharmacoeconomic benefits versus oral nimodipine.
  • The update ties into Grace's overall regulatory strategy and corporate presentation.
  • Grace aims to address leachable and manufacturing issues to advance NDA resubmission.
Vote 0
0
#6
Shoulder Innovations launches InSet I-135RFX after FDA clearance to cover fracture indications
#6 out of 264
business5m ago

Shoulder Innovations launches InSet I-135RFX after FDA clearance to cover fracture indications

  • Shoulder Innovations launched the InSet I-135RFX humeral stem commercially after expanded FDA clearance.
  • The device supports primary, revision and fracture procedures under the InSet line.
  • The InSet I-135RFX is built on the company’s lateral-lateral philosophy to reduce complications.
  • Surgeons report ease of use and straightforward technique with the system.
  • The InSet I-135RFX follows a limited market release before full commercialization.
  • The announcement ties to the company’s SEC filings and strategic product lineup.
Vote 0
0
#7
Arm appoints Dr. Daniel Gilmer to Board effective April 24, 2026
#7 out of 264
business5m ago

Arm appoints Dr. Daniel Gilmer to Board effective April 24, 2026

  • Arm appoints Dr. Daniel Gilmer to its Board of Directors, effective April 24, 2026.
  • The announcement notes Gilmer will participate in standard non-management director compensation.
  • The appointment has an expected option award of 51,280 shares vesting over three years.
  • The exercise price for the options is the fair market value on the grant date.
  • Dr. Gilmer is 39 years old and will participate in the standard compensation arrangement.
  • The company did not disclose background details beyond the applicant’s age.
  • The original SEC filing related to the appointment is referenced in the summary.
  • The summary was produced by an AI and may contain inaccuracies; verification is advised.
  • TradingView reports latest news and analysis surrounding Arm's board appointment.
Vote 0
0
#8
Bacteria in your mouth may travel to the gut and trigger stomach cancer, research finds
#8 out of 264
health9m ago

Bacteria in your mouth may travel to the gut and trigger stomach cancer, research finds

  • New research links mouth bacteria with gastric cancer risk, showing oral microbes matching gut bacteria in patients.
  • Study analyzed 404 samples from Chinese patients with gastric cancer or gastritis to explore microbiome links.
  • Researchers emphasize saliva and stool samples could help detect cancer patterns, pending further validation.
  • Experts describe an 'initiator-promoter' model, noting microbiome migration between mouth and gut may influence cancer development.
  • Researchers say altering the microbiome might help treat or prevent cancers when used with immunotherapy or chemotherapy.
  • Study authors caution results show association, not proven causation between mouth bacteria and cancer.
  • The work highlights how oral bacteria like Streptococcus and lactobacillus appear linked to gastric cancer in patients.
  • Experts see potential for saliva-based cancer detection if findings are validated in future research.
  • Study publication underscores the oral-gut microbiome axis as a potential focus for early cancer detection.
  • The study was reported by Fox News Digital and included input from multiple physicians.
Vote 0
0
#9
Compass reports positive COMPANION-002 PFS and ORR results; plans FDA meeting
#9 out of 264
health5m ago

Compass reports positive COMPANION-002 PFS and ORR results; plans FDA meeting

  • Compass reports COMPANION-002 shows a significant ORR benefit for tovecimig plus paclitaxel vs paclitaxel alone.
  • PFS improved to 4.7 months vs 2.6 months with a hazard ratio of 0.44 (p<0.0001).
  • Overall survival did not reach significance due to high crossover, though pooled OS reached 8.9 months.
  • Crossover analyses show longer OS for crossover patients (12.8 vs 6.1 months; HR=0.54, p=0.04).
  • Safety was consistent with prior studies; hypertension and fatigue were common in the combination arm.
  • Compass plans an FDA meeting to discuss COMPANION-002 results and next steps.
  • The COMPANION-002 trial enrolled 168 participants to assess tovecimig with paclitaxel.
  • The study used a crossover design, influencing OS interpretation.
  • The source material is an AI-powered summary of SEC filings and related disclosures.
  • TradingView served as the source for the summarized market data on Compass Therapeutics.
Vote 0
0
#10
Eton Pharmaceuticals doses first patient in ET-700 pilot study; topline results expected H2 2026
#10 out of 264
health5m ago

Eton Pharmaceuticals doses first patient in ET-700 pilot study; topline results expected H2 2026

  • ETON Pharma dosed the first patient in a double-blind pilot study of ET-700 for Wilson disease.
  • The study arms include ET-700, GALZIN, and placebo with a four-week treatment period.
  • Primary endpoint measures the change in hepatic copper uptake via 64Cu PET.
  • topline results are expected in the second half of 2026, potentially guiding a pivotal study.
  • The trial is conducted at Aarhus University with 36 healthy volunteers.
  • ET-700 is an extended‑release zinc acetate formulation under evaluation for Wilson disease.
  • A potential pivotal study could follow a positive pilot outcome in early 2027.
  • The study compares ET-700 with GALZIN and placebo to assess copper handling.
  • Topline results will be released in the second half of 2026.
  • The Financial SEC filing context is noted in the source summary.
Vote 0
0

Explore Your Interests

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement